Clinical Trials Directory

Trials / Unknown

UnknownNCT05728606

Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Hebei Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety of robot-assisted radical gastrectomy with D2 lymph node dissection in postoperative complications in patients with neoadjuvant chemotherapy for gastric cancer (cT3-4a, N+, M0).

Conditions

Interventions

TypeNameDescription
PROCEDURERobot-assisted D2 distal gastrectomyRobot-assisted D2 distal gastrectomy after 3-Cycle SOX neoadjuvant chemotherapy

Timeline

Start date
2023-01-20
Primary completion
2024-06-20
Completion
2024-06-20
First posted
2023-02-15
Last updated
2023-02-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05728606. Inclusion in this directory is not an endorsement.

Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers (NCT05728606) · Clinical Trials Directory